Edition:
India

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

37.94USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$37.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,950
52-wk High
$44.38
52-wk Low
$13.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 7.81 -0.023
Jun '17 0.00 -0.697
FY 2016 Dec '16 17.53 1.122
Sep '16 0.00 -3.731
Jun '16 0.00 -1.702
Mar '16 0.00 -1.811
FY 2015 Dec '15 0.00 -0.678
Sep '15
Mar '15 0.00 -0.196
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 --
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 4 7.87 8.00 7.80 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 4 -0.68 -0.67 -0.69 --
Quarter Ending Mar-18 2 -0.64 -0.57 -0.71 --
Year Ending Dec-17 4 -2.13 -1.98 -2.50 --
Year Ending Dec-18 4 -2.71 -2.47 -2.95 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 67.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Urogen Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.46%
# of Holders: 37
Total Shares Held: 5,595,685
3 Mo. Net Change: 281,087
# New Positions: 17
# Closed Positions: 4
# Increased Positions: 22
# Reduced Positions: 10
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.